← All Synergy Chc CORP filings

Synergy Chc CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
SNYR
Synergy Chc CORP
SCHEDULE 13G/A: Knight Therapeutics Boosts Stake in Synergy CHC Corp. to 19.90%
Knight Therapeutics Inc. has reported an increased beneficial ownership stake of 19.90% in Synergy CHC Corp., including shares held directly and through warrants.
NASDAQ
SNYR
Synergy Chc CORP
SCHEDULE 13G: Knight Therapeutics Discloses 17.03% Stake in Synergy CHC Corp.
Knight Therapeutics Inc. has reported a 17.03% beneficial ownership stake in Synergy CHC Corp., totaling 1,482,844 shares, as of December 31, 2024.